Список проголосовавших за комментарий " LHC Group initiation details — Buy at The Benchmark Company; tgt $55 (46.96)The Benchmark Company initiates LHCG with a Buy and price target of $55. As one of the largest scale players in home health, LHCG is positioned to benefit from emerging healthcare delivery trends. Financial incentives are increasingly focused on low cost/high quality care — and home health is often the most viable post-acute alternative. Competitive advantages for LHCG include its long history of large hospital partnerships; heavy concentration in CON states; strong clinical systems driving high quality scores necessary for new Medicare payments, and a sterling financial condition to support continued M&A."